Overall outcomes. (A) Cumulative incidence of aGVHD grades 2 to 4 at 100 days. (B) Cumulative incidence of aGVHD grades 3 to 4 at 100 days. (C) Cumulative incidence of cGVHD moderate/severe at 12 months. (D) Cumulative incidence of relapse at 12 months. (E) Cumulative incidence of NRM at 12 months. (F) GRFS at 12 months. (G) OS at 12 months.